• Helps to fat excretion
• Absorbs fat and sugar
• Supports healthy weight management

Neopuntia TM is a natural weight management pure cactus powder. Neopuntia TM is a patented combination of insoluble and soluble dietary fibers.


Nexira and Tunisian farmers maintain a long-term partnership which respects both organic rules and sustainable harvesting of Opuntia ficus indica. Through its cactus sourcing, Nexira is involved in sustainable development via environmental, human and economic actions.

With over 20 years of experience and unrivalled expertise on cactus sourcing and processing, Nexira offers a standardized pure cactus leaf powder. Neopuntia TM is perfect for nutraceutical applications.

In vitro1 study, simulating gastrointestinal tract conditions, has demonstrated a reduction of fat absorption: 28% of ingested fat binds to Neopuntia TM while branded chitosan showed no effect.

A pilot clinical study2 has also demonstrated results on human: Neopuntia TM increases fat excretion by 27%.

Neopuntia TM absorbs fat and sugar3 and supports healthy weight management.

A published clinical study4 shows Neopuntia TM, consumed with a healthy diet, has positive effects on balancing blood lipids levels. Neopuntia TM helps to increase HDL cholesterol level.

39% of women studied no longer showed Syndrome X criteria using Neopuntia TM.

Three interventional studies in human demonstrated positive and significant glycaemia modulation5,6,7.

Neopuntia TM is a nutraceutical ingredient used in supplements and functional food.

  • Organic grade available
  • Pure cactus powder

Learn more about our Cactus sourcing expertise, download our infographic.




Need more information or samples?

Contact us

Sources :
(93001) In vitro simulation of GI track assessing the bio-accessibility of fat when ingested with 2g dose of NeOpuntiaTM(9300works of 2001, 2004 and 2005 – TNO).
(93002) NeOpuntiaTM and faecal fat excretion 2003. Pilot study, double blinded, randomized, placebo-controlled, administration of 3×1.6gr of NeOpuntia for 7 days.
(93003) EU pending claim ID 2733 – at least 2g leaves daily.
(93004) Linares, E et al. 2007. The effect of NeOpuntia® on blood Lipid parameters – risk factors for the Metabolic Syndrome (Syndrome X).
(93005) Frati, A. et al. 1990. Hypoglycemic effect of Opuntia ficus indica in non insulin_dependent diabetes mellitus patients.
(93006) López-Romero, P. et al. 2014. The effect of nopal (Opuntia ficus indica) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts.
(93007) Aiello, A. et al. 2018. Targeting Aging with Functional Food: Pasta with Opuntia Single-Arm Pilot Study.

This communication is not intended to the final consumer. It provides scientific information for professionals only. Communications to the final consumer have to be checked according to local regulations in force, since the conditions of use are beyond our control. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.